Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析

◆英語タイトル:Fresenius Medical Care AG & Co KGaA (FME) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1603
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Fresenius Medical Care AG & Co KGaA (FME) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Fresenius Medical Care AG & Co KGaA (Fresenius Medical Care), a subsidiary of Fresenius SE & Co KGaA, is an integrated dialysis company. It provides dialysis care services and products to individuals with chronic kidney failure. It develops and manufactures a comprehensive range of dialysis machines, systems and disposable products. The company also offers Care Coordination services including pharmacy services, vascular, cardiovascular and endovascular specialty services, non-dialysis laboratory testing services, physician services, hospitalist and intensivist services, health plan services and urgent care services. The company provides dialysis treatment at its clinics and also sells its products to other dialysis service providers. It conducts its operations through its subsidiaries in Europe, the Middle East, Africa, the Americas and Asia-Pacific. Fresenius Medical Care is headquartered in Bad Homburg, Germany.

Fresenius Medical Care AG & Co KGaA Key Recent Developments

Apr 23,2020 Fresenius Medical Care North America names New Chief Medical Officer for Renal Therapies Group
Apr 01,2020 Fresenius Medical Care partners with other dialysis providers to combat coronavirus pandemic in the U.S.
Feb 19,2020 Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth
Nov 06,2019 Fresenius Medical Care North America presents new insights for kidney Care at the American Society of Nephrology (ASN) Annual Kidney Week

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Fresenius Medical Care AG & Co KGaA – Key Facts
Fresenius Medical Care AG & Co KGaA – Key Employees
Fresenius Medical Care AG & Co KGaA – Key Employee Biographies
Fresenius Medical Care AG & Co KGaA – Major Products and Services
Fresenius Medical Care AG & Co KGaA – History
Fresenius Medical Care AG & Co KGaA – Company Statement
Fresenius Medical Care AG & Co KGaA – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Fresenius Medical Care AG & Co KGaA – Business Description
Business Segment: Health Care Products
Overview
Performance
Key Stats
Business Segment: Health Care Services
Overview
Performance
Key Stats
Geographical Segment: Asia-Pacific
Performance
Geographical Segment: Corporate
Performance
Geographical Segment: EMEA
Performance
Geographical Segment: Latin America
Performance
Geographical Segment: North America
Performance
R&D Overview
Fresenius Medical Care AG & Co KGaA – Corporate Strategy
Fresenius Medical Care AG & Co KGaA – SWOT Analysis
SWOT Analysis – Overview
Fresenius Medical Care AG & Co KGaA – Strengths
Fresenius Medical Care AG & Co KGaA – Weaknesses
Fresenius Medical Care AG & Co KGaA – Opportunities
Fresenius Medical Care AG & Co KGaA – Threats
Fresenius Medical Care AG & Co KGaA – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Type, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 23, 2020: Fresenius Medical Care North America names New Chief Medical Officer for Renal Therapies Group
Apr 01, 2020: Fresenius Medical Care partners with other dialysis providers to combat coronavirus pandemic in the U.S.
Feb 19, 2020: Fresenius Medical Care achieves 2019 guidance and confirms 2020 outlook of sustainable, profitable growth
Nov 06, 2019: Fresenius Medical Care North America presents new insights for kidney Care at the American Society of Nephrology (ASN) Annual Kidney Week
Nov 04, 2019: Fresenius Medical Care North America announces availability of advanced water purification systems for Hemodialysis
Oct 29, 2019: Fresenius Medical Care again delivers strong organic growth in the third quarter
Oct 29, 2019: Fresenius Medical Care appoints Dr. Frank Maddux to management board, makes global chief medical officer a board position
Oct 28, 2019: Fresenius Medical Care celebrates 10th anniversary and expansion of their dialysis center with enhanced home therapy support in Perth, Western Australia
Oct 22, 2019: Donate Life America and the Fresenius Medical Care Foundation announce groundbreaking National, Universal Living Donor Kidney Registry
Oct 17, 2019: More people in Phnom Penh living with kidney disease will have access to dialysis
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Fresenius Medical Care AG & Co KGaA, Key Facts
Fresenius Medical Care AG & Co KGaA, Key Employees
Fresenius Medical Care AG & Co KGaA, Key Employee Biographies
Fresenius Medical Care AG & Co KGaA, Major Products and Services
Fresenius Medical Care AG & Co KGaA, History
Fresenius Medical Care AG & Co KGaA, Subsidiaries
Fresenius Medical Care AG & Co KGaA, Key Competitors
Fresenius Medical Care AG & Co KGaA, Ratios based on current share price
Fresenius Medical Care AG & Co KGaA, Annual Ratios
Fresenius Medical Care AG & Co KGaA, Annual Ratios (Cont...1)
Fresenius Medical Care AG & Co KGaA, Annual Ratios (Cont...2)
Fresenius Medical Care AG & Co KGaA, Interim Ratios
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Type, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Fresenius Medical Care AG & Co KGaA, Performance Chart (2015 - 2019)
Fresenius Medical Care AG & Co KGaA, Ratio Charts
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals By Year, 2014 to YTD 2020
Fresenius Medical Care AG & Co KGaA, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Fresenius Medical Care AG & Co KGaA (FME):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Meghmani Organics Ltd (MEGH):企業の財務・戦略的SWOT分析
    Summary Meghmani Organics Ltd (Meghmani Organics) is a chemical product manufacturing company. The company develops, produce and markets pigments and pesticides. Its pigments include pigments for plastics, pigments for printing inks and pigments for coatings. Meghmani Organics’ pesticides comprise f …
  • Hitachi Zosen Corp (7004):企業の財務・戦略的SWOT分析
    Hitachi Zosen Corp (7004) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • HeartWare International Inc-医療機器分野:企業M&A・提携分析
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that co …
  • Hydro-Quebec:電力:M&Aディール及び事業提携情報
    Summary Hydro-Quebec is a government-owned energy utility that generates, transmits and distributes electricity. The company specializes in renewable energy generation, using hydro sources and supports the development of electricity using other technologies such as wind energy and biomass. It genera …
  • Origin Energy Limited:戦略・SWOT・企業財務分析
    Origin Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Origin Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • ReWalk Robotics Ltd (RWLK):医療機器:M&Aディール及び事業提携情報
    Summary ReWalk Robotics Ltd (ReWalk) is a medical device company that designs, develops and commercializes exoskeletons. The company provides walk restoration devices for people with lower limb disabilities to stand and walk once again. Its products include ReWalk personal system and ReWalk rehabili …
  • Mega Corporation Ltd
    Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Mega Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Lockheed Martin Australia Pty Ltd:企業の戦略・SWOT・財務情報
    Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Australia Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Clean Harbors, Inc. (CLH):企業の財務・戦略的SWOT分析
    Clean Harbors, Inc. (CLH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • The Hershey Co:企業の戦略・SWOT・財務情報
    The Hershey Co - Strategy, SWOT and Corporate Finance Report Summary The Hershey Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • PPL Corp (PPL):企業の財務・戦略的SWOT分析
    PPL Corp (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • NovaBay Pharmaceuticals Inc (NBY)-医療機器分野:企業M&A・提携分析
    Summary NovaBay Pharmaceuticals Inc (NovaBay), formerly NovaCal Pharmaceuticals Inc is a biopharmaceutical company that develops eyecare products. The company’s products include daily lid and lash hygiene spray solution, skin and wound cleanser, and cosetic procedures. Its daily lid and lash hygiene …
  • CSI Compressco LP (CCLP):石油・ガス:M&Aディール及び事業提携情報
    Summary CSI Compressco LP (CSI), formerly Compressco Partners LP, a subsidiary of TETRA Technologies Inc, is an oilfield consulting company that offers compression services and equipment for natural gas and oil production, transportation, and storage. The company's products include real-time compres …
  • Mapi Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mapi Pharma Ltd (Mapi Pharma) is a clinical stage pharmaceutical company that offers development of active pharmaceutical ingredients and formulations, and life cycle management products. The company’s lead products include Glatiramer Acetate Depot, an injection for the treatment of multiple …
  • Angelini Group:企業の戦略的SWOT分析
    Angelini Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • UnitedHealth Group Inc (UNH):製薬・医療:M&Aディール及び事業提携情報
    Summary UnitedHealth Group Inc (UnitedHealth Group) is a diversified health care company. It offers health care services and products through two distinct platforms, namely UnitedHealthcare and Optum. Its UnitedHealthcare platform provides health care coverage and benefit services; and Optum platfor …
  • Flexion Therapeutics Inc (FLXN):企業の財務・戦略的SWOT分析
    Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • United Spirits Ltd:企業の戦略・SWOT・財務情報
    United Spirits Ltd - Strategy, SWOT and Corporate Finance Report Summary United Spirits Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Veritone, Inc. (VERI):企業の財務・戦略的SWOT分析
    Veritone, Inc. (VERI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • MasTec Inc (MTZ):企業の財務・戦略的SWOT分析
    MasTec Inc (MTZ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆